You are here
Home > Renal > Meropenem

Usual Dosing (Adults)

Usual: 1 gram IV q8h.
Complicated skin/skin structure infections: 500 mg IV q8h.
Intra-abdominal infections: 1 gram IV q8h.
Meningitis: 2 gram IV q8h.

Renal Dosing

dialysis [CRCL >50]: no change

[26-50]: Usual: 1 gram q12h.
 (UTI, skin/ skin structure infections): 500mg q12h

[10-25]: Usual:  500 mg q12h.
 (UTI, skin/ skin structure infections): 250mg q12h

[<10]: Usual:  500mg q24h.
  (UTI, skin/ skin structure infections): 250mg q24h


dialysis Package insert:
There is inadequate information regarding the use of MERREM I.V. in patients on hemodialysis.

There is no experience with peritoneal dialysis.


500mg q24h + 500mg after each HD

500mg q24h.


National Institutes of Health, U.S. National Library of Medicine, DailyMed Database.
Provides access to the latest drug monographs submitted to the Food and Drug Administration (FDA). Please review the latest applicable package insert for additional information and possible updates.  A local search option of this data can be found here.


The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user’s use of or reliance upon this material.PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER. Read the disclaimer